Targeting Breast Cancer Stem Cells to Overcome Treatment Resistance

Despite advances in breast cancer diagnosis and treatment, many patients still fail therapy, resulting in disease progression, recurrence, and reduced overall survival. Historically, much focus has been put on the intrinsic subtyping based in the presence (or absence) of classical immunohistochemist...

Descripción completa

Detalles Bibliográficos
Autores principales: Palomeras, Sònia, Ruiz-Martínez, Santiago, Puig, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225226/
https://www.ncbi.nlm.nih.gov/pubmed/30200262
http://dx.doi.org/10.3390/molecules23092193

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225226/
https://www.ncbi.nlm.nih.gov/pubmed/30200262
http://dx.doi.org/10.3390/molecules23092193

Ejemplares similares